Cancer BiologybioRxivPreprint
Proximity proteome mapping reveals PD-L1-dependent pathways disrupted by anti-PD-L1 antibody specifically in EGFR-mutant lung cancer cells.
A. Letian, E. Y. Lemma, P. Cavaliere…·T. E. McGraw
The paper uses proximity proteome mapping to show that anti-PD-L1 therapy disrupts specific PD-L1-dependent pathways in EGFR-mutant lung cancer cells, leading to altered cell migration and EGFR stability.
DOI 10.1101/2021.09.17.460833